 | |
- close
- close
|
PR Newswire
Nov 16
Comment
SEATTLE, Nov. 16 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (the "Company") today announced that the Company's product candidate PX-866, a PI-3 kinase inhibitor, has been selected by Windhover Information, Inc., as one of the Top 10
StreetInsider.com
Nov 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncothyreon+%28ONTY%29+Reports+Worse-Than-Expected+Q3+Loss+of+%240.24/5098462.html for the full story.
PR Newswire
Nov 11
Comment
SEATTLE, Nov. 11 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported financial results for the three and nine months ended September 30, 2009 and provided a product pipeline update. Management will hold a conference call today at
PR Newswire
Nov 2
Comment
SEATTLE, Nov. 2 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its third
TheStreet.com
Oct 16
Comment
Readers write in about Oncothyreon, Progenics, Chelsea Therapeutics and more.
PR Newswire
Oct 5
Comment
SEATTLE, Oct. 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) today announced the appointment of Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, Inc. (Nasdaq: ZGEN), to its board of directors. "We are
PR Newswire
Sep 3
Comment
SEATTLE, WA, Sept. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the Rodman Renshaw 11th Annual Healthcare Conference taking
newratings.com
Aug 13
Comment
NEW YORK, August 13 (newratings.com) - Analysts at Boenning & Scattergood reiterate their "outperform" rating on Oncothyreon (ticker: ONTY). The target price has been raised from $5 to $8. [more]
StreetInsider.com
Aug 12
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncothyreon+Inc.+%28ONTY%29+Reports+Q2+EPS+Results/4870417.html for the full story.
StreetInsider.com
Aug 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Oncothyreon+%28ONTY%29+Reports+Presentation+of+Long-Term+Stimuvax+Data+at+13th+World+Conference+on+Lung+Cancer/4837745.html for the full story.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
ONTY AT A GLANCE
References
| ||||||
|
|
